MyFinsight
Home
Blog
About
Cash and cash
equivalents
$12,617,594
(150.60%↑ Y/Y)
Prepaid expenses
$2,776,722
(101.31%↑ Y/Y)
Other current assets
$835,418
(-39.43%↓ Y/Y)
Other receivables
$456,429
(142.63%↑ Y/Y)
Total current assets
$16,686,163
(152.73%↑ Y/Y)
Other non-current
assets
$2,554,166
(138.73%↑ Y/Y)
Property and equipment,
net
$1,419,796
(-14.04%↓ Y/Y)
Finance lease
right-of-use asset
$872,388
(-67.69%↓ Y/Y)
Operating lease
right-of-use assets
$837,596
(-12.35%↓ Y/Y)
Total assets
$22,370,109
(72.35%↑ Y/Y)
Accumulated deficit
-$194,671,566
(-5.98%↓ Y/Y)
Accumulated other
comprehensive loss
-$374,856
(6.94%↑ Y/Y)
Total liabilities and
stockholders' (deficit)...
$22,370,109
(72.35%↑ Y/Y)
Total stockholders'
(deficit) equity
-$560,100
(95.60%↑ Y/Y)
Additional paid-in capital
$194,484,046
(13.50%↑ Y/Y)
Common stock, 0.0001
par value...
$1,517
(68.00%↑ Y/Y)
Preferred stock, 0.01 par
value, 5,000,000...
$759
Total liabilities
$22,930,209
(-10.82%↓ Y/Y)
Total current
liabilities
$16,922,620
(-11.96%↓ Y/Y)
Liability related to the
sale of future...
$5,733,717
(17.52%↑ Y/Y)
Lease liabilities
long-term, operating
$273,872
(-38.90%↓ Y/Y)
Deferred grant funding
$14,954,724
(21.32%↑ Y/Y)
Accounts payable
$762,914
(-56.72%↓ Y/Y)
Current portion of lease
liabilities, operating
$594,493
(1.02%↑ Y/Y)
Accrued expenses
$448,945
(-82.21%↓ Y/Y)
Current portion of lease
liability, finance
$149,374
(-91.84%↓ Y/Y)
Current portion of
liability related to the...
$12,170
(-93.53%↓ Y/Y)
Back
Back
Balance Sheet
Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. (DARE)
source: myfinsight.com